External dataset validation and functional experiments confirmed that silencing BAMBI, MAPK8IP2, or BMP7 directly altered oxaliplatin sensitivity in CRC cell lines, supporting their potential as predictive biomarkers. Here, BAMBI is linked to colorectal carcinoma.